Drug misuse and dependency

Services

Drugs Test 1 (DT1) form

Form for the testing of specified class A drugs on persons ages 18 or over.

Controlled drugs list
- Guidance
- 8 August 2022
- Home Office
Preventing drug and alcohol deaths: partnership review process
- Guidance
- 26 September 2024
- Office for Health Improvement and Disparities
Drug misuse and dependence: UK guidelines on clinical management
- Guidance
- 15 December 2017
- Department of Health and Social Care
Recovery support services and lived experience initiatives
- Guidance
- 10 October 2024
- Office for Health Improvement and Disparities
ASSIST-Lite screening tool: how to use
- Guidance
- 7 April 2021
- Closed organisation: Public Health England

ACMD advice on reform to hemp licensing fees
- 23 October 2024
- Advisory Council on the Misuse of Drugs
- Correspondence
Virtual reality and wearable technology pilot to cut drug deaths
- 18 October 2024
- Department of Health and Social Care, Office for Life Sciences, and Department for Science, Innovation and Technology
- Press release
Britain takes decisive action to ban 'zombie drug' xylazine
- 4 September 2024
- Home Office
- News story
Licensed drug testing continues at music festivals this summer
- 24 May 2024
- Home Office
- News story
Government response to the ACMD's report on novel benzodiazepines
- 14 May 2024
- Home Office and Advisory Council on the Misuse of Drugs
- Correspondence

Deaths linked to potent synthetic opioids
- 3 October 2024
- Office for Health Improvement and Disparities
- Research
Alkyl nitrites: ACMD exemption consideration
- 9 August 2024
- Advisory Council on the Misuse of Drugs
- Research
Improving Lives: Helping Workless Families indicators 2024
- 21 May 2024
- Department for Work and Pensions
- Research
Drug and alcohol treatment for victims and suspects of homicide
- 28 March 2024
- Office for Health Improvement and Disparities and Home Office
- Official statistics
Uncontrolled novel benzodiazepines: 2024 update
- 28 March 2024
- Advisory Council on the Misuse of Drugs
- Research

Proposals to expand access to take-home naloxone supplies
- 14 May 2024
- Department of Health and Social Care, Department of Health (Northern Ireland), The Scottish Government, and Welsh Government
- Consultation outcome
- Date closed 06 March 2024
Expanding access to naloxone
- 24 January 2024
- Department of Health and Social Care
- Consultation outcome
- Date closed 28 September 2021
Drug prevention policies and landscape across the UK
- 5 January 2024
- Home Office and Advisory Council on the Misuse of Drugs
- Closed call for evidence
ACMD internet-facilitated drug markets review
- 20 December 2023
- Home Office and Advisory Council on the Misuse of Drugs
- Closed call for evidence
Drug use in ethnic minority groups
- 21 September 2023
- Home Office and Advisory Council on the Misuse of Drugs
- Closed call for evidence

Drug Testing on Arrest (DToA): programme data
- 21 August 2024
- Home Office
- Transparency
From harm to hope: first annual report 2022 to 2023
- 27 February 2024
- Home Office
- Corporate report
Rough sleeping drug and alcohol treatment grant: privacy notice
- 22 July 2022
- Office for Health Improvement and Disparities
- Corporate report
Doctor licensing for diamorphine prescribing: privacy notice
- 22 July 2022
- Office for Health Improvement and Disparities
- Corporate report
Individual Placement and Support (IPS-AD) trial: privacy notice
- 28 January 2022
- Office for Health Improvement and Disparities
- Corporate report